Browse By Region
Browse By Category
By Category: Agents & Toxins
(Washington Post)- Ancient Egyptians used copper to sterilize chest wounds and drinking water. Greeks, Romans and Aztecs relied on copper compounds to treat burns, headaches and ear infections. Thousands of years later, the ancient therapeutic is being embraced by some hospitals because of its ability to kill bacteria and other microbes on contact, which can Read More »
- September 21, 2015
(Global Biodefense) The National Institute of Allergy and Infectious Diseases (NIAID) has released a new Broad Agency Announcement (BAA) to support development of therapeutic products for use in post-event settings following the intentional release or natural outbreak of high priority biological threats. Countermeasures are sought for Ebola and other filoviruses, Clostridium botulinum, Yersinia pestis, Francisella Read More »
- July 16, 2015
The U.S. Department of Defense (DoD) is conducting market research on manufacturing capabilities for the nerve agent antidote scopolamine for intramuscular administration.
- April 9, 2015
The Defense Advanced Research Projects Agency (DARPA) has announced a new Technologies for Host Resilience (THoR) Broad Agency Announcement (BAA) to catalyze the development of breakthrough interventions that would increase the ability of patients’ own bodies to tolerate a broad range of pathogens.
- April 9, 2015
The Joint Project Management Medical Countermeasure Systems (JPM-MCS), as part of the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), has issued a Request For Information (RFI) for the advanced development, procurement, fielding, and sustainment of medical treatment, prophylactic, and diagnostic capabilities against chemical, biological, radiological, and nuclear (CBRN) warfare agents.
- April 2, 2015